A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Blood Cancer, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2010 |
| End Date: | April 2011 |
A Phase 1 Study to Assess the Effect of a CYP3A Inducer (Rifampin) on the Pharmacokinetics of Navitoclax
This is an open-label, single or multiple center study to determine the interaction of
rifampin with navitoclax (ABT-263) in approximately 12 subjects with cancer.
We found this trial at
1
site
Click here to add this to my saved trials
